{
    "id": 19818,
    "fullName": "PIK3CB positive",
    "impact": "unknown",
    "proteinEffect": "unknown",
    "geneVariantDescriptions": [
        {
            "description": "PIK3CB positive indicates the presence of the Pik3cb gene, mRNA, and/or protein.",
            "references": [
                {
                    "id": 275,
                    "pubMedId": null,
                    "title": "External Reference Not Available (N/A)",
                    "url": "https://ckb.jax.org/about/glossaryOfTerms"
                }
            ]
        }
    ],
    "type": "non-specific",
    "gene": {
        "id": 5291,
        "geneSymbol": "PIK3CB",
        "terms": [
            "PIK3CB",
            "P110BETA",
            "PI3K",
            "PI3KBETA",
            "PIK3C1"
        ]
    },
    "variant": "positive",
    "createDate": "03/15/2016",
    "updateDate": "04/29/2018",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 5076,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, LY294002 inhibited proliferation and induced apoptosis in acute promyelocytic leukemia cell lines expressing endogenous Pik3ca, Pik3cb, and Pik3cd in culture (PMID: 19176369).",
            "molecularProfile": {
                "id": 20238,
                "profileName": "PIK3CA pos PIK3CB pos PIK3CD pos"
            },
            "therapy": {
                "id": 1062,
                "therapyName": "LY294002",
                "synonyms": null
            },
            "indication": {
                "id": 60318,
                "name": "acute promyelocytic leukemia",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 4874,
                    "pubMedId": 19176369,
                    "title": "Inhibition of class I phosphoinositide 3-kinase activity impairs proliferation and triggers apoptosis in acute promyelocytic leukemia without affecting atra-induced differentiation.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/19176369"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 5077,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, IC87114 moderately inhibited proliferation of acute promyelocytic leukemia cell lines expressing endogenous Pik3ca, Pik3cb, and Pik3cd in culture (PMID: 19176369).",
            "molecularProfile": {
                "id": 20238,
                "profileName": "PIK3CA pos PIK3CB pos PIK3CD pos"
            },
            "therapy": {
                "id": 3504,
                "therapyName": "IC87114",
                "synonyms": null
            },
            "indication": {
                "id": 60318,
                "name": "acute promyelocytic leukemia",
                "source": "DOID"
            },
            "responseType": "decreased response",
            "references": [
                {
                    "id": 4874,
                    "pubMedId": 19176369,
                    "title": "Inhibition of class I phosphoinositide 3-kinase activity impairs proliferation and triggers apoptosis in acute promyelocytic leukemia without affecting atra-induced differentiation.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/19176369"
                }
            ],
            "ampCapAscoEvidenceLevel": "NA",
            "ampCapAscoInferredTier": "NA"
        },
        {
            "id": 5075,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, PI-103 inhibited proliferation of acute promyelocytic leukemia cell lines expressing endogenous Pik3ca, Pik3cb, and Pik3cd in culture (PMID: 19176369).",
            "molecularProfile": {
                "id": 20238,
                "profileName": "PIK3CA pos PIK3CB pos PIK3CD pos"
            },
            "therapy": {
                "id": 870,
                "therapyName": "PI-103",
                "synonyms": null
            },
            "indication": {
                "id": 60318,
                "name": "acute promyelocytic leukemia",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 4874,
                    "pubMedId": 19176369,
                    "title": "Inhibition of class I phosphoinositide 3-kinase activity impairs proliferation and triggers apoptosis in acute promyelocytic leukemia without affecting atra-induced differentiation.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/19176369"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 5074,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, TGX-155 moderately inhibited proliferation of acute promyelocytic leukemia cell lines expressing endogenous Pik3ca, Pik3cb, and Pik3cd in culture (PMID: 19176369).",
            "molecularProfile": {
                "id": 20238,
                "profileName": "PIK3CA pos PIK3CB pos PIK3CD pos"
            },
            "therapy": {
                "id": 3503,
                "therapyName": "TGX-155",
                "synonyms": null
            },
            "indication": {
                "id": 60318,
                "name": "acute promyelocytic leukemia",
                "source": "DOID"
            },
            "responseType": "decreased response",
            "references": [
                {
                    "id": 4874,
                    "pubMedId": 19176369,
                    "title": "Inhibition of class I phosphoinositide 3-kinase activity impairs proliferation and triggers apoptosis in acute promyelocytic leukemia without affecting atra-induced differentiation.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/19176369"
                }
            ],
            "ampCapAscoEvidenceLevel": "NA",
            "ampCapAscoInferredTier": "NA"
        },
        {
            "id": 5078,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, Rapamune (sirolimus) moderately inhibited proliferation of acute promyelocytic leukemia cell lines expressing endogenous Pik3ca, Pik3cb, and Pik3cd in culture (PMID: 19176369).",
            "molecularProfile": {
                "id": 20238,
                "profileName": "PIK3CA pos PIK3CB pos PIK3CD pos"
            },
            "therapy": {
                "id": 917,
                "therapyName": "Sirolimus",
                "synonyms": null
            },
            "indication": {
                "id": 60318,
                "name": "acute promyelocytic leukemia",
                "source": "DOID"
            },
            "responseType": "decreased response",
            "references": [
                {
                    "id": 4874,
                    "pubMedId": 19176369,
                    "title": "Inhibition of class I phosphoinositide 3-kinase activity impairs proliferation and triggers apoptosis in acute promyelocytic leukemia without affecting atra-induced differentiation.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/19176369"
                }
            ],
            "ampCapAscoEvidenceLevel": "NA",
            "ampCapAscoInferredTier": "NA"
        },
        {
            "id": 5160,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, PI-3065 did not inhibit growth of Pik3ca and Pik3cb-positive breast cancer cells with undetectable Pik3cd and Pik3cg protein level in culture, but resulted in tumor regression in allograft animal models through upregulation of host anti-tumor immune response (PMID: 24919154).",
            "molecularProfile": {
                "id": 20277,
                "profileName": "PIK3CA pos PIK3CB pos PIK3CD dec exp PIK3CG dec exp"
            },
            "therapy": {
                "id": 2965,
                "therapyName": "PI-3065",
                "synonyms": null
            },
            "indication": {
                "id": 1612,
                "name": "breast cancer",
                "source": "DOID"
            },
            "responseType": "predicted - sensitive",
            "references": [
                {
                    "id": 3350,
                    "pubMedId": 24919154,
                    "title": "Inactivation of PI(3)K p110\u03b4 breaks regulatory T-cell-mediated immune tolerance to cancer.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/24919154"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 20236,
            "profileName": "PIK3CB positive",
            "profileTreatmentApproaches": [
                
            ]
        },
        {
            "id": 20238,
            "profileName": "PIK3CA pos PIK3CB pos PIK3CD pos",
            "profileTreatmentApproaches": [
                
            ]
        },
        {
            "id": 20277,
            "profileName": "PIK3CA pos PIK3CB pos PIK3CD dec exp PIK3CG dec exp",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}